Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Redmile Group and Alder Biopharmaceuticals Inc (ALDR)

Page 1 of 9

Alder Biopharmaceuticals Inc (NASDAQ:ALDR): Jeremy Green’s Redmile Group filed an amended 13D.

You can check out Redmile Group’s latest holdings and filings here.

Please follow Redmile Group (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Redmile Group or update its stock holdings.

Jeremy Green
Jeremy Green
Redmile Group

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Redmile Group 0 6,807,876 0 6,807,876 6,807,876 9.99%
Jeremy C. Green CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) o (b) o SEC USE ONLY SOURCE OF FUNDS (SEE INSTRUCTIONS) OO 0 6,807,876 0 6,807,876 6,807,876 9.99%
Jeremy Green
Jeremy Green
Redmile Group

Page 1 of 9 – SEC Filing


UNITED STATES

SECURITIES &
EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Follow Alder Biopharmaceuticals Inc (NASDAQ:ALDR)
Trade (NASDAQ:ALDR) Now!
Page 1 of 9
Loading...